Logo image of CVKD

CADRENAL THERAPEUTICS INC (CVKD) Stock Income Statement

NASDAQ:CVKD - Nasdaq - US1276362076 - Common Stock - Currency: USD

19.89  +0.66 (+3.46%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
Revenue
CVKD Revenue ChartCVKD Revenue over time chart
0.000.000.00
Operating Expenses
CVKD Operating Expenses ChartCVKD Operating Expenses over time chart
7.63M2.70MN/A
Research and Development
CVKD Research and Development ChartCVKD Research and Development over time chart
4.08M390.00KN/A
Selling, General, and Administrative Expenses
CVKD Selling, General, and Administrative Expenses ChartCVKD Selling, General, and Administrative Expenses over time chart
3.55M2.31MN/A
Operating Income
CVKD Operating Income ChartCVKD Operating Income over time chart
-7.63M-2.70M0.00
Interest Income/Expense
CVKD Interest Income/Expense ChartCVKD Interest Income/Expense over time chart
15.90K-4.01MN/A
Non Recurring Items
CVKD Non Recurring Items ChartCVKD Non Recurring Items over time chart
-740.14KN/AN/A
Income Before Taxes
CVKD Income Before Taxes ChartCVKD Income Before Taxes over time chart
-8.36M-6.71MN/A
Income Tax
CVKD Income Tax ChartCVKD Income Tax over time chart
N/A0.00N/A
Net Income
CVKD Net Income ChartCVKD Net Income over time chart
-8.36M-6.71MN/A
EBITDA
CVKD EBITDA ChartCVKD EBITDA over time chart
-7.63MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
CVKD EPS Diluted Total Ops ChartCVKD EPS Diluted Total Ops over time chart
-9.29-0.85N/A
 
Statistics

All data in USD

Charts

CVKD Income Statement data chartCVKD Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2021 2022 2023 -2M -4M -6M -8M
CVKD Earnings Per Share (EPS) chartCVKD EPS Diluted and non-GAAP ChartEarnings Per Share 2021 2022 2023 -2 -4 -6 -8